ALS Reaffirms FY27 Outlook as Growth Strategy and Digital Transformation Progress
ALS Limited (ASX: ALQ) has reaffirmed its FY27 outlook during its Annual General Meeting, highlighting continued progress under its "Roadmap to Win" strategy and confidence in delivering high single-digit organic revenue growth with steady margin expansion. Following a record FY26, the Company reported that first-quarter trading remains in line with expectations, supported by stronger-than-anticipated growth in its Minerals division, improving Life Sciences performance and continued investment in automation and digital capabilities through its Lab of the Future initiative. ALS also announced the appointment of Rajkumar Mathiravedu as Global Executive General Manager – Minerals, further strengthening its leadership team, while confirming an agreement to increase its ownership in its Saudi joint venture from 42% to 60%, subject to regulatory approvals. With a strong balance sheet, disciplined capital allocation and ongoing investment in technology and operational excellence, ALS remains focused on delivering sustainable long-term growth.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
ALS Reaffirms FY27 Outlook as Growth Strategy and Digital Transformation Progress
ALS Limited (ASX: ALQ) has reaffirmed its FY27 outlook during its Annual General Meeting, highlighting continued progress under its "Roadmap to Win" strategy and confidence in delivering high single-digit organic revenue growth with steady margin expansion. Following a record FY26, the Company reported that first-quarter trading remains in line with expectations, supported by stronger-than-anticipated growth in its Minerals division, improving Life Sciences performance and continued investment in automation and digital capabilities through its Lab of the Future initiative. ALS also announced the appointment of Rajkumar Mathiravedu as Global Executive General Manager – Minerals, further strengthening its leadership team, while confirming an agreement to increase its ownership in its Saudi joint venture from 42% to 60%, subject to regulatory approvals. With a strong balance sheet, disciplined capital allocation and ongoing investment in technology and operational excellence, ALS remains focused on delivering sustainable long-term growth.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au